Phase 1
Completed N=50
Motivational Interviewing to Improve Medication Adherence Among Hispanic Adults With Depression
Source: ClinicalTrials.gov NCT00356304 ↗Enrolled (actual)
50
Serious AEs
0.0%
Results posted
May 2014
Primary outcomePrimary: Medication Adherence, as Measured by Electronic Pill Container — 58.76; 34.7 Percentage of Days — p=<.05
Summary
This study will determine the effectiveness of motivational interviewing in improving antidepressant medication adherence among Hispanics.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Medication Adherence, as Measured by Electronic Pill Container |
58.76; 34.7 | <.05 sig |
| SECONDARY Treatment Retention |
— | — |
| SECONDARY Beck Depression Inventory-II (BDI-II) |
16.75; 23.03 | — |
| SECONDARY Medication Attitudes |
— | — |
Eligibility Criteria
Inclusion Criteria
- Self-identifies as Hispanic
- DSM-IV diagnosis of any unipolar depressive disorder (i.e., MDD, dysthymia, or depressive disorder not otherwise specified)
- Currently taking antidepressant medication
Exclusion Criteria
- Clinically significant suicidal ideation
- DSM-IV diagnosis of any substance-related disorder, bipolar disorder, or psychotic disorder/features within 12 months prior to study entry
- Unstable general medical condition
Data sourced from ClinicalTrials.gov (NCT00356304). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.